相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Metabolic syndrome and cardiovascular diseases: Going beyond traditional risk factors
Joao Leonardo Silveira Rossi et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2022)
Integrated Multi-Omics for Novel Aging Biomarkers and Antiaging Targets
Lei Wu et al.
BIOMOLECULES (2022)
Determining the effect size of aerobic exercise training on the standard lipid profile in sedentary adults with three or more metabolic syndrome factors: a systematic review and meta-analysis of randomised controlled trials
Gina Wood et al.
BRITISH JOURNAL OF SPORTS MEDICINE (2022)
Continuous metabolic syndrome severity score and the risk of CVD and all-cause mortality
Xiaoya Tang et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2022)
Targeting Gut Microbiota With Natural Polysaccharides: Effective Interventions Against High-Fat Diet-Induced Metabolic Diseases
Chao-Yue Sun et al.
FRONTIERS IN MICROBIOLOGY (2022)
Transplantation of Gut Microbiota From High-Fat-Diet-Tolerant Cynomolgus Monkeys Alleviates Hyperlipidemia and Hepatic Steatosis in Rats
Jiang-Mei Gao et al.
FRONTIERS IN MICROBIOLOGY (2022)
Effect of Washed Microbiota Transplantation on Patients With Dyslipidemia in South China
Fenfen Liang et al.
FRONTIERS IN ENDOCRINOLOGY (2022)
Long-term efficacy and safety of moderate-intensity statin with ezetimibe combination therapy versus high-intensity statin monotherapy in patients with atherosclerotic cardiovascular disease (RACING): a randomised, open-label, non-inferiority trial
Byeong-Keuk Kim et al.
LANCET (2022)
Beneficial Effects of Repeated Washed Microbiota Transplantation in Children With Autism
Zhao-Yu Pan et al.
FRONTIERS IN PEDIATRICS (2022)
Washed microbiota transplantation improves patients with high blood glucose in South China
Lei Wu et al.
FRONTIERS IN ENDOCRINOLOGY (2022)
Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials
Naveed Sattar et al.
LANCET DIABETES & ENDOCRINOLOGY (2021)
Gene-level metagenomic architectures across diseases yield high-resolution microbiome diagnostic indicators
Braden T. Tierney et al.
NATURE COMMUNICATIONS (2021)
Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial
Julio Rosenstock et al.
LANCET (2021)
Once-weekly tirzepatide versus once-daily insulin degludec as add-on to metformin with or without SGLT2 inhibitors in patients with type 2 diabetes (SURPASS-3): a randomised, open-label, parallel-group, phase 3 trial
Bernhard Ludvik et al.
LANCET (2021)
Washed Microbiota Transplantation Lowers Blood Pressure in Patients With Hypertension
Hao-Jie Zhong et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2021)
Metagenomics-Based Analysis of the Age-Related Cumulative Effect of Antibiotic Resistance Genes in Gut Microbiota
Lei Wu et al.
ANTIBIOTICS-BASEL (2021)
EU-Wide Cross-Sectional Observational Study of Lipid-Modifying Therapy Use in Secondary and Primary Care: the DA VINCI study
Kausik K. Ray et al.
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2021)
Effects of Fecal Microbiota Transplantation With Oral Capsules in Obese Patients
Jessica R. Allegretti et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2020)
Donor metabolic characteristics drive effects of faecal microbiota transplantation on recipient insulin sensitivity, energy expenditure and intestinal transit time
Pieter de Groot et al.
GUT (2020)
Washed microbiota transplantation vs. manual fecal microbiota transplantation: clinical findings, animal studies and in vitro screening
Ting Zhang et al.
PROTEIN & CELL (2020)
Risk for cardiovascular disease associated with metabolic syndrome and its components: a 13-year prospective study in the RIVANA cohort
Maria J. Guembe et al.
CARDIOVASCULAR DIABETOLOGY (2020)
The Global Burden of Cardiovascular Diseases and Risks A Compass for Global Action
Gregory A. Roth et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
Critical Role of the Interaction Gut Microbiota - Sympathetic Nervous System in the Regulation of Blood Pressure
Marta Toral et al.
FRONTIERS IN PHYSIOLOGY (2019)
Molecular characterization of alterations in the intestinal microbiota of patients with grade 3 hypertension
Nosheen Mushtaq et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2019)
Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2
Evan Bolyen et al.
NATURE BIOTECHNOLOGY (2019)
Fecal Microbial Transplantation and Its Potential Application in Cardiometabolic Syndrome
Avner Leshem et al.
FRONTIERS IN IMMUNOLOGY (2019)
Atherosclerosis
Peter Libby et al.
NATURE REVIEWS DISEASE PRIMERS (2019)
Effects of Lactobacillus Casei YBJ02 on Lipid Metabolism in Hyperlipidemic Mice
Yu Qian et al.
JOURNAL OF FOOD SCIENCE (2019)
Parabacteroides distasonis Alleviates Obesity and Metabolic Dysfunctions via Production of Succinate and Secondary Bile Acids
Kai Wang et al.
CELL REPORTS (2019)
Curcumin as a potential candidate for treating hyperlipidemia: A review of cellular and metabolic mechanisms
Yunes Panahi et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2018)
Composition and metabolism of fecal microbiota from normal and overweight children are differentially affected by melibiose, raffinose and raffinose-derived fructans
Kaarel Adamberg et al.
ANAEROBE (2018)
fastp: an ultra-fast all-in-one FASTQ preprocessor
Shifu Chen et al.
BIOINFORMATICS (2018)
Gut Microbiota as a Therapeutic Target for Metabolic Disorders
Hirofumi Okubo et al.
CURRENT MEDICINAL CHEMISTRY (2018)
Obesity Pathophysiology and Management
Kishore M. Gadde et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
The gut microbiota and the brain-gut-kidney axis in hypertension and chronic kidney disease
Tao Yang et al.
NATURE REVIEWS NEPHROLOGY (2018)
Effects of Qijian mixture on type 2 diabetes assessed by metabonomics, gut microbiota and network pharmacology
Kuo Gao et al.
PHARMACOLOGICAL RESEARCH (2018)
Effect of Vegan Fecal Microbiota Transplantation on Carnitine- and Choline-Derived Trimethylamine-N-Oxide Production and Vascular Inflammation in Patients With Metabolic Syndrome
Loek P. Smits et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2018)
The use of faecal microbiota transplant as treatment for recurrent or refractory Clostridium difficile infection and other potential indications: joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines
Benjamin H. Mullish et al.
GUT (2018)
Infant Feeding and Weight Gain: Separating Breast Milk From Breastfeeding and Formula From Food
Meghan B. Azad et al.
PEDIATRICS (2018)
Fecal microbiota transplantation confers beneficial metabolic effects of diet and exercise on diet-induced obese mice
Zi-Lun Lai et al.
SCIENTIFIC REPORTS (2018)
Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the American Heart Association
Robert M. Carey et al.
HYPERTENSION (2018)
High-Fiber Diet and Acetate Supplementation Change the Gut Microbiota and Prevent the Development of Hypertension and Heart Failure in Hypertensive Mice
Francine Z. Marques et al.
CIRCULATION (2017)
Improved Glucose Homeostasis in Obese Mice Treated With Resveratrol Is Associated With Alterations in the Gut Microbiome
Miranda M. Sung et al.
DIABETES (2017)
A purified membrane protein from Akkermansia muciniphila or the pasteurized bacterium improves metabolism in obese and diabetic mice
Hubert Plovier et al.
NATURE MEDICINE (2017)
Faecal Microbiota Transplantation for Inflammatory Bowel Disease: A Systematic Review and Meta-analysis
Sudarshan Paramsothy et al.
JOURNAL OF CROHNS & COLITIS (2017)
Gut microbiota - at the intersection of everything?
Patrice D. Cani
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2017)
Alterations of the Gut Microbiome in Hypertension
Qiulong Yan et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2017)
Microbial Anti-Inflammatory Molecule (MAM) from Faecalibacterium prausnitzii Shows a Protective Effect on DNBS and DSS-Induced Colitis Model in Mice through Inhibition of NF-κB Pathway
Natalia M. Breyner et al.
FRONTIERS IN MICROBIOLOGY (2017)
Next-Generation Beneficial Microbes: The Case of Akkermansia muciniphila
Patrice D. Cani et al.
FRONTIERS IN MICROBIOLOGY (2017)
Gut microbiota dysbiosis contributes to the development of hypertension
Jing Li et al.
MICROBIOME (2017)
The risk of inflammatory bowel disease flares after fecal microbiota transplantation: Systematic review and meta-analysis
Taha Qazi et al.
GUT MICROBES (2017)
Improvement of Insulin Sensitivity after Lean Donor Feces in Metabolic Syndrome Is Driven by Baseline Intestinal Microbiota Composition
Ruud S. Kootte et al.
CELL METABOLISM (2017)
Methods and Reporting Studies Assessing Fecal Microbiota Transplantation A Systematic Review
Aida Bafeta et al.
ANNALS OF INTERNAL MEDICINE (2017)
Independent associations between a metabolic syndrome severity score and future diabetes by sex and race: the Atherosclerosis Risk In Communities Study and Jackson Heart Study
Matthew J. Gurka et al.
DIABETOLOGIA (2017)
Durable coexistence of donor and recipient strains after fecal microbiota transplantation
Simone S. Li et al.
SCIENCE (2016)
Metabolic syndrome update
Scott M. Grundy
TRENDS IN CARDIOVASCULAR MEDICINE (2016)
Characterization of the Gut Microbial Community of Obese Patients Following a Weight-Loss Intervention Using Whole Metagenome Shotgun Sequencing
Sandrine Louis et al.
PLOS ONE (2016)
Systematic Review: Adverse Events of Fecal Microbiota Transplantation
Sinan Wang et al.
PLOS ONE (2016)
Severity of the metabolic syndrome as a predictor of type 2 diabetes between childhood and adulthood: the Princeton Lipid Research Cohort Study
Mark D. DeBoer et al.
DIABETOLOGIA (2015)
Fecal Microbiota Transplantation Induces Remission in Patients With Active Ulcerative Colitis in a Randomized Controlled Trial
Paul Moayyedi et al.
GASTROENTEROLOGY (2015)
Gut Dysbiosis Is Linked to Hypertension
Tao Yang et al.
HYPERTENSION (2015)
Cost-Effectiveness Analysis of Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection
Raghu U. Varier et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2015)
Optimum and stepped care standardised antihypertensive treatment with or without renal denervation for resistant hypertension (DENERHTN): a multicentre, open-label, randomised controlled trial
Michel Azizi et al.
LANCET (2015)
Hypocholesterolemic effects of Lactobacillus reuteri LR6 in rats fed on high-cholesterol diet
Tejinder Pal Singh et al.
INTERNATIONAL JOURNAL OF FOOD SCIENCES AND NUTRITION (2015)
Metabolic syndrome: a closer look at the growing epidemic and its associated pathologies
S. O'Neill et al.
OBESITY REVIEWS (2015)
Microbial Modulation of Insulin Sensitivity
Muhammad Tanweer Khan et al.
CELL METABOLISM (2014)
A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis
Kathleen Machiels et al.
GUT (2014)
Effect of Probiotics on Blood Pressure A Systematic Review and Meta-Analysis of Randomized, Controlled Trials
Saman Khalesi et al.
HYPERTENSION (2014)
Long-term Drug Treatment for Obesity A Systematic and Clinical Review
Susan Z. Yanovski et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
Fecal microbiota transplantation: effectiveness, complexities, and lingering concerns
E. G. Pamer
MUCOSAL IMMUNOLOGY (2014)
Long term maintenance of weight loss with non-surgical interventions in obese adults: systematic review and meta-analyses of randomised controlled trials
S. U. Dombrowski et al.
BMJ-BRITISH MEDICAL JOURNAL (2014)
Gut Microbiota from Twins Discordant for Obesity Modulate Metabolism in Mice
Vanessa K. Ridaura et al.
SCIENCE (2013)
Antihypertensive Efficacy of Hydrochlorothiazide vs Chlorthalidone Combined with Azilsartan Medoxomil
George L. Bakris et al.
AMERICAN JOURNAL OF MEDICINE (2012)
Transfer of Intestinal Microbiota From Lean Donors Increases Insulin Sensitivity in Individuals With Metabolic Syndrome
Anne Vrieze et al.
GASTROENTEROLOGY (2012)
Sequential nephron blockade versus sequential renin-angiotensin system blockade in resistant hypertension: a prospective, randomized, open blinded endpoint study
Guillaume Bobrie et al.
JOURNAL OF HYPERTENSION (2012)
Gut Microbiota Modulate the Metabolism of Brown Adipose Tissue in Mice
Renaud Mestdagh et al.
JOURNAL OF PROTEOME RESEARCH (2012)
A metagenome-wide association study of gut microbiota in type 2 diabetes
Junjie Qin et al.
NATURE (2012)
FLASH: fast length adjustment of short reads to improve genome assemblies
Tanja Magoc et al.
BIOINFORMATICS (2011)
Chimeric 16S rRNA sequence formation and detection in Sanger and 454-pyrosequenced PCR amplicons
Brian J. Haas et al.
GENOME RESEARCH (2011)
Differential Adaptation of Human Gut Microbiota to Bariatric Surgery-Induced Weight Loss Links With Metabolic and Low-Grade Inflammation Markers
Jean-Pierre Furet et al.
DIABETES (2010)
The metabolic syndrome: useful concept or clinical tool? Report of a WHO Expert Consultation
R. K. Simmons et al.
DIABETOLOGIA (2010)
The gut microbiota modulates host energy and lipid metabolism in mice
Vidya R. Velagapudi et al.
JOURNAL OF LIPID RESEARCH (2010)
The core gut microbiome, energy balance and obesity
Peter J. Turnbaugh et al.
JOURNAL OF PHYSIOLOGY-LONDON (2009)
Efficacy of Atorvastatin Reload in Patients on Chronic Statin Therapy Undergoing Percutaneous Coronary Intervention Results of the ARMYDA-RECAPTURE (Atorvastatin for Reduction of Myocardial Damage During Angioplasty) Randomized Trial
Germano Di Sciascio et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
Novel Approaches for Preventing or Limiting Events (Naples) II Trial Impact of a Single High Loading Dose of Atorvastatin on Periprocedural Myocardial Infarction
Carlo Briguori et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
Appropriate Physical Activity Intervention Strategies for Weight Loss and Prevention of Weight Regain for Adults
Joseph E. Donnelly et al.
MEDICINE AND SCIENCE IN SPORTS AND EXERCISE (2009)
Metabolic syndrome pandemic
Scott M. Grundy
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2008)
New Drugs for Type 2 Diabetes Mellitus What is their Place in Therapy?
Andrew J. Krentz et al.
DRUGS (2008)
The Human Microbiome Project
Peter J. Turnbaugh et al.
NATURE (2007)
Metabolic syndrome and risk of incident cardiovascular events and death - A systematic review and meta-analysis of longitudinal studies
Apoor S. Gami et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
分享论文
